About Newtec Vascular Products

About company

Newtec Vascular Products Ltd is developing a device which addresses Neo Intimal Hyperplasia - the blockage of vessels by scar tissue as a result of vascular graft surgery. The device has shown good efficacy in pre-clinical studies and Newtec are currently preparing for their first-in-man trials. FloGuardian™ has the potential to be used in more than 2 million procedures per year with a market potential of more than £800m.